Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|10|7|772-781

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.10, Iss.7, 2010-11, pp. : 772-781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

High Expression of CXCR4 and CXCR7 Predicts Poor Survival in Gallbladder Cancer

By Yao X   Zhou L   Han S   Chen Y  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1253-1264

Field House Publishing

Access to resources Recommend Favorite

High CXCR4 Expression Correlates with Sunitinib Poor Response in Metastatic Renal Cancer

By  

Current Cancer Drug Targets, Vol. 12, Iss. 6, 2012-07 ,pp. : 693-702

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1441-1451

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 515-519

Bentham Science Publishers

Access to resources Recommend Favorite

DFO and DMOG up-regulate the expression of CXCR4 in bone marrow mesenchymal stromal cells

By Yinfei Wu   Aiping Jin   Chao Feng   Yanxin Zhao   Xueyuan Liu  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 10, 2013-10 ,pp. : 835-838

Govi-Verlag

Access to resources Recommend Favorite